Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
HER3 Vaccine for Cancer
Recruiting1 awardPhase 1
Durham, North Carolina
This trial is testing a vaccine that produces the full length human HER3 protein to target cancers that express the human epidermal growth factor receptor HER3. The objectives of the study are to determine the safety and tolerability of the vaccine and to see if it can cause a HER3 specific immune response in patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service